DYNACURE
Dynacure is a clinical-stage drug development company focused on improving the lives of patients with rare and orphan diseases.The Dynacure team leverages its proven track record in rare disease drug development to build a pipeline of novel drugs. Dynacure is developing DYN101, an investigational antisense medicine designed to modulate the expression of dynamin 2 for the treatment of Centronuclear Myopathies, with Ionis Pharmaceuticals. Dynacure is also building a complementary research portfolio targeting other orphan disorders.
DYNACURE
Industry:
Biotechnology Health Care Life Science Pharmaceutical
Founded:
2016-01-01
Address:
Illkirch, Alsace, France
Country:
France
Website Url:
http://www.dynacure.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
100.27 M EUR
Technology used in webpage:
Euro Person Schema Gravatar Profiles Combell
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Arctoris
Arctoris is a tech-enabled platform company in biotechnology, combining robotics & data science to accelerate drug discovery.
Lyra Therapeutics
Lyra Therapeutics is a clinical-stage company developing medicines to treat ear, nose, and throat diseases.
Viteava Pharmaceuticals
Viteava is a start-up drug development company focused on improving the treatment and management of cancer and related conditions.
Current Advisors List
Current Employees Featured
Founder
Investors List
Kurma Partners
Kurma Partners investment in Series C - Dynacure
Bpifrance
Bpifrance investment in Series C - Dynacure
Perceptive Advisors
Perceptive Advisors investment in Series C - Dynacure
Andera Partners
Andera Partners investment in Series C - Dynacure
Pontifax
Pontifax investment in Series C - Dynacure
Tekla Capital Management
Tekla Capital Management investment in Series C - Dynacure
Pontifax
Pontifax investment in Series A - Dynacure
Kurma Partners
Kurma Partners investment in Series A - Dynacure
Bpifrance
Bpifrance investment in Series A - Dynacure
Andera Partners
Andera Partners investment in Series A - Dynacure
Official Site Inspections
http://www.dynacure.com Semrush global rank: 1.26 M Semrush visits lastest month: 23.77 K
- Host name: linweb232.webhosting.be
- IP address: 83.217.70.125
- Location: Belgium
- Latitude: 50.8509
- Longitude: 4.3447
- Timezone: Europe/Brussels
More informations about "Dynacure"
Flamingo Therapeutics and Dynacure Announce …
Mar 2, 2023 Leuven (Belgium), Strasbourg (France), Philadelphia (USA)- March 2, 2023 /PRNewswire/-- Flamingo Therapeutics (“Flamingo”) and Dynacure, announced today that the companies have signed a definitive merger …See details»
Dynacure - Crunchbase Company Profile & Funding
Dynacure is a clinical-stage drug development company focused on improving the lives of patients with rare and orphan diseases.The Dynacure team leverages its proven track record in rare …See details»
Flamingo Therapeutics and Dynacure Announce Merger to Create …
Mar 2, 2023 "The merger of Flamingo and Dynacure is a great strategic fit for both companies, leveraging a wealth of RNA therapeutic expertise and cancer drug development, and …See details»
Flamingo Therapeutics and Dynacure Announce Merger to Create …
Management and Organization The combined company will be led by Dynacure’ Chief Executive Officer, Stéphane van Rooijen (MD, MBA) – who will become the combined company’s Chief …See details»
Flamingo Therapeutics and Dynacure Announce Merger to Create …
Mar 2, 2023 “The merger of Flamingo and Dynacure is a great strategic fit for both companies, leveraging a wealth of RNA therapeutic expertise and cancer drug development, and …See details»
Flamingo and Dynacure Merge to Create RNA Therapeutics …
Mar 2, 2023 “The merger of Flamingo and Dynacure is a great strategic fit for both companies, leveraging a wealth of RNA therapeutic expertise and cancer drug development, and …See details»
Flamingo Therapeutics, Dynacure Merge to Form New Company …
Mar 2, 2023 "The merger of Flamingo and Dynacure is a great strategic fit for both companies, leveraging a wealth of RNA therapeutic expertise and cancer drug development, and …See details»
Flamingo Therapeutics acquires Dynacure - 2023-03-02
Mar 2, 2023 Acquired Organization: Dynacure Dynacure is a clinical-stage drug development company focused on improving the lives of patients with rare and orphan diseases. Acquiring …See details»
Flamingo folds Dynacure into its flamboyance in …
Mar 2, 2023 Flamingo Therapeutics is standing on one leg no more, as Dynacure folds into the biotech in a merger agreement that will see the combined company work on RNA-targeted oncology therapies ...See details»
Flamingo Therapeutics and Dynacure Announce Merger… | Leuven …
"The merger of Flamingo and Dynacure is a great strategic fit for both companies, leveraging a wealth of RNA therapeutic expertise and cancer drug development, and combining teams to …See details»
Flamingo Therapeutics and Dynacure Announce Merger to Create …
Mar 3, 2023 Therapeutics (“Flamingo”) and Dynacure, announced today that the companies have signed a definitive merger agreement to combine their pipelines and expertise to create a …See details»
Flamingo Therapeutics merges with Dynacure - flanders.bio
Mar 2, 2023 Stephane van Rooijen, CEO of Flamingo Therapeutics: “The merger of Flamingo and Dynacure is a great strategic fit for both companies, leveraging a wealth of RNA …See details»
Dynacure - Org Chart, Teams, Culture & Jobs | The Org
View Dynacure's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Dynacure - Funding, Financials, Valuation & Investors - Crunchbase
Dynacure is a clinical-stage drug development company focused on improving the lives of patients with rare and orphan diseases.See details»
'Overwhelmed with disappointment', Dynacure axes top asset
Jul 7, 2022 The news came in a letter published by an advocacy and research organization focused on the rare diseases. 'Overwhelmed with disappointment', Dynacure axes top asset …See details»
Dynacure Company Profile - Craft
Dynacure has 5 employees at their 1 location and $113.47 m in total funding,. See insights on Dynacure including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Dynacure Receives Fast Track Designation for DYN101, an …
STRASBOURG, Pa., Jan. 6, 2022 /PRNewswire/ -- Dynacure, a clinical stage biotechnology company focusing on Myotubular and Centronuclear Myopathies (CNM), a group of rare, …See details»
Dynacure Announces FDA Acceptance of Investigational New Drug ...
Jun 9, 2021 STRASBOURG, France and PHILADELPHIA, June 9, 2021 /PRNewswire/ -- Dynacure, a clinical-stage company focused on developing and commercializing novel …See details»
Dynacure - Contacts, Employees, Board Members, Advisors
Organization. Dynacure . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 6. Number of Board …See details»
Dynacure to Present Preclinical Data on Disease Progression …
Sep 16, 2021 STRASBOURG, France and PHILADELPHIA, Sept. 16, 2021 /PRNewswire/ -- Dynacure, a clinical-stage company focused on developing and commercializing novel …See details»